Metoprolol tartrate tablets orange peel book information

Brief introduction: metoprolol tartrate is a selective β - 1 adrenergic receptor blocker On April 18, 1975, metoprolol tartrate tablets were listed in Sweden by AstraZeneca, with the trade name of seloken and specifications of 50mg and 100mg It is mainly used to treat hypertension, angina, myocardial infarction and other diseases In 1992, metoprolol tartrate sustained-release tablets were first marketed in Japan, with the trade name of 120mg The original approval number of metoprolol tartrate tablets in China is: swyzz (1985) No 326201, with the trade name of Betaloc, holding company AstraZeneca Pharmaceutical Co., Ltd Since 1991, domestic enterprises have obtained the approval of metoprolol tartrate sustained-release tablets At present, the raw materials of Astra zenecaab company are imported from Sweden in China There is no preparation import, only the original research and localization varieties Japan has listed the original research products of metoprolol tartrate tablets, and the holding companies are Astra Zeneca K.K and Novartis Pharma K.K.; however, the specifications of common metoprolol tartrate tablets in Japan are 20mg and 40mg, which are not suitable as reference preparations Original overseas listing: domestic sales of metoprolol tartrate tablets domestic listing product pattern expansion information of metoprolol tartrate in the United States (2) listing information of the United States (71) drug registration information (27) bid winning information of drugs (767) Chinese drug standard (5) foreign standard information (57) drug instruction information (4) reference preparation supplier